$BHVN news
The latest BHVN stock news: headlines, filings, AI summaries and sentiment for $BHVN, updated around the clock.
- Biohaven Reports Q3 GAAP EPS Miss of $0.08
- Ono Pharmaceutical Reports Q2 GAAP EPS of ¥95.60 and 11.2% Growth in Six-Month Operating Profit
- Biohaven Licenses IgG Degrader Portfolio to Ono Pharmaceutical
- Midday Market Moves: Oracle, AeroVironment, American Eagle, Micron, Macy's Among Notable Movers
- Biohaven Pauses Midstage Study of Seizure Treatment, Impact on Xenon
- Biohaven Shares Drop Following RBC Downgrade
- ATI Reports Strong Q2 Results, Raises Guidance Amid Record Backlog
- Biohaven Licenses Epilepsy Candidate Opakalim for $795 Million
- Federal Jury Awards $4 Million to Yale University and Biohaven in Trade Secret Misappropriation Case Against Avilar Therapeutics and RA Capital
- Biohaven Completes Enrollment in RISE3 Trial for Opakalim